Cargando…

Myelosuppression in Patients Treated with the Telomerase Inhibitor Imetelstat Is Not Mediated through Activation of Toll-Like Receptors

Imetelstat sodium (GRN163L; hereafter, imetelstat) is a first-in-class telomerase inhibitor that has demonstrated activity in patients with myeloproliferative neoplasms (MPNs). Treatment with imetelstat has been associated with thrombocytopenia and other hematologic adverse effects that were managea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baerlocher, Gabriela M., Rusbuldt, Joshua, Bussolari, Jacqueline, Huang, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555816/ https://www.ncbi.nlm.nih.gov/pubmed/32911605 http://dx.doi.org/10.3390/ijms21186550

Ejemplares similares

Dynamics of mutations in patients with essential thrombocythemia treated with imetelstat
por: Leibundgut, Elisabeth Oppliger, et al.
Publicado: (2020)

Imetelstat (a telomerase antagonist) exerts off-target effects on the cytoskeleton
por: MENDER, ILGEN, et al.
Publicado: (2013)

Telomerase Inhibitor Imetelstat (GRN163L) Limits the Lifespan of Human Pancreatic Cancer Cells
por: Burchett, Katrina M., et al.
Publicado: (2014)

Telomerase antagonist imetelstat increases radiation sensitivity in esophageal squamous cell carcinoma
por: Wu, Xuping, et al.
Publicado: (2017)

Telomerase-targeting compounds Imetelstat and 6-thio-dG act synergistically with chemotherapy in high-risk neuroblastoma models
por: Fischer-Mertens, Janina, et al.
Publicado: (2022)

Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner
por: Frink, Robin E., et al.
Publicado: (2016)

The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling
por: Olschok, Kathrin, et al.
Publicado: (2023)

P1008: THE TELOMERASE INHIBITOR IMETELSTAT DIFFERENTIALLY TARGETS JAK2V617F- VERSUS CALR-MUTANT MYELOPROLIFERATIVE NEOPLASM CELLS AND INHIBITS JAK-STAT SIGNALING
por: Olschok, Kathrin, et al.
Publicado: (2023)

Imetelstat therapy in refractory anemia with ring sideroblasts with or without thrombocytosis
por: Tefferi, A, et al.
Publicado: (2016)

Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors
por: Kumar, R, et al.
Publicado: (2009)

S169: MODULATION OF THE IMMUNE LANDSCAPE IN LOWER-RISK MYELODYSPLASTIC SYNDROMES WITH IMETELSTAT-INDUCED TRANSFUSION INDEPENDENCY
por: Chapuis, Nicolas, et al.
Publicado: (2023)

Collapse of Telomere Homeostasis in Hematopoietic Cells Caused by Heterozygous Mutations in Telomerase Genes
por: Aubert, Geraldine, et al.
Publicado: (2012)

Sleeping through the storm: Preventing myelosuppression with quizartinib
por: Taylor, Samuel J., et al.
Publicado: (2017)

Imetelstat Induces Leukemia Stem Cell Death in Pediatric Acute Myeloid Leukemia Patient-Derived Xenografts
por: Barwe, Sonali P., et al.
Publicado: (2022)

Translational Modeling of Drug‐Induced Myelosuppression and Effect of Pretreatment Myelosuppression for AZD5153, a Selective BRD4 Inhibitor
por: Collins, TA, et al.
Publicado: (2017)

Mycobacterial signaling through toll-like receptors
por: Basu, Joyoti, et al.
Publicado: (2012)

Ulvan Activates Chicken Heterophils and Monocytes Through Toll-Like Receptor 2 and Toll-Like Receptor 4
por: Guriec, Nathalie, et al.
Publicado: (2018)

The impact of antifungals on toll-like receptors
por: Mihu, Mircea R., et al.
Publicado: (2014)

Piperacillin/tazobactam Induced Myelosuppression
por: Lee, Kirsty Wai Chung, et al.
Publicado: (2009)

Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
por: Xun, Yang, et al.
Publicado: (2021)

Toll-like Receptor 4 Modulation as a Strategy to Treat Sepsis
por: Wittebole, X., et al.
Publicado: (2010)

Fungal pathogens—a sweet and sour treat for toll-like receptors
por: Bourgeois, Christelle, et al.
Publicado: (2012)

Toll-Like Receptors in Atherosclerosis
por: Falck-Hansen, Mika, et al.
Publicado: (2013)

Toll-Like Receptors in Angiogenesis
por: Grote, Karsten, et al.
Publicado: (2011)

Toll-like Receptors and Thrombopoiesis
por: Tang, Xiaoqin, et al.
Publicado: (2023)

The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the Endosome
por: Petes, Carlene, et al.
Publicado: (2017)

The association of four genetic variants with myelosuppression in gemcitabine‐treated Japanese is not evident in gemcitabine/carboplatin‐treated Swedes
por: Björn, Niclas, et al.
Publicado: (2022)

Protective effects on myelosuppression mice treated by three different classic Chinese medicine formulae
por: Zhao, An-bin, et al.
Publicado: (2011)

The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy
por: Zecha, Judith A. E. M., et al.
Publicado: (2019)

Integrated approaches for the recognition of small molecule inhibitors for Toll-like receptor 4
por: Verma, Shailya, et al.
Publicado: (2023)

Myelosuppression by sunitinib is flt-3 genotype dependent
por: van Erp, N P, et al.
Publicado: (2010)

Antineoplastics: Myelosuppression and COVID-19: case report
Publicado: (2020)

Palbociclib: Myelosuppression and gastrointestinal reactions: case report
Publicado: (2022)

Toll-like receptors and NOD-like receptors in rheumatic diseases
por: McCormack, William J, et al.
Publicado: (2009)

Toll-like receptor downstream signaling
por: Kawai, Taro, et al.
Publicado: (2005)

Toll-Like Receptors and Myocardial Inflammation
por: Feng, Yan, et al.
Publicado: (2011)

Toll-Like Receptors of Deuterostome Invertebrates
por: Satake, Honoo, et al.
Publicado: (2012)

Innate immunity and Toll-like receptors
por: O'Neill, LAJ
Publicado: (2004)

Toll-Like Receptors and Skin Cancer
por: Burns, Erin M., et al.
Publicado: (2014)

Toll-Like Receptors and Prostate Cancer
por: Zhao, Shu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_832e0fh48rcrcpb44udi3mjoso